{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:34:13Z","timestamp":1791477253149,"version":"4.3.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.juro.2016.04.046","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T10:25:36Z","timestamp":1464949536000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment"],"prefix":"10.1097","volume":"196","author":[{"given":"Eric","family":"Rovner","sequence":"first","affiliation":[{"name":"Department of Urology, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Kohan","sequence":"additional","affiliation":[{"name":"Advanced Urology Centers of New York, Bethpage, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chartier-Kastler","sequence":"additional","affiliation":[{"name":"Department of Urology, Piti\u00e9-Salp\u00e9tri\u00e8re Academic Hospital, University Paris 6, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"J\u00fcnemann","sequence":"additional","affiliation":[{"name":"Department of Urology and Pediatric Urology, Klinik f\u00fcr Urologie und Kinderurologie, Universit\u00e4tsklinikum Schleswig-Holstein, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Del Popolo","sequence":"additional","affiliation":[{"name":"Department of Neurourology, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sender","family":"Herschorn","sequence":"additional","affiliation":[{"name":"Division of Urology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manher","family":"Joshi","sequence":"additional","affiliation":[{"name":"Allergan plc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Magyar","sequence":"additional","affiliation":[{"name":"Allergan plc, Bridgewater, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Nitti","sequence":"additional","affiliation":[{"name":"Department of Urology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.04.046_bib1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib3","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S1569-9056(14)60683-7","article-title":"Consistent long-term efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity: final results after 4 years\u2019 follow-up","volume":"13","author":"Karsenty","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib4","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1016\/j.juro.2014.02.2535","article-title":"Sustained improvements in urinary incontinence and quality of life over long-term treatment with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity","volume":"191","author":"Kennelly","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib5","article-title":"Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity","author":"Chartier-Kastler","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2016.04.046_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sc.2012.174","article-title":"Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity","volume":"51","author":"Stohrer","year":"2013","journal-title":"Spinal Cord"},{"key":"10.1016\/j.juro.2016.04.046_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sc.2014.113","article-title":"Are\u00a0oxybutynin and trospium efficacious in the\u00a0treatment of detrusor overactivity in spinal\u00a0cord injury patients?","volume":"52","author":"Hadiji","year":"2014","journal-title":"Spinal Cord"},{"key":"10.1016\/j.juro.2016.04.046_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.0b013e3182a2ca4d","article-title":"OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity","volume":"81","author":"Chancellor","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.juro.2016.04.046_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/nau.22293","article-title":"Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity","volume":"32","author":"Sussman","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2016.04.046_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib11","series-title":"Guidelines on Neuro-Urology","author":"Blok","year":"2015"},{"key":"10.1016\/j.juro.2016.04.046_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/AOG.0b013e31818e8aa4","article-title":"Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms","volume":"112","author":"Gopal","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.juro.2016.04.046_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sc.2013.19","article-title":"Neurogenic detrusor overactivity in adults: a\u00a0review on efficacy, tolerability and safety of oral antimuscarinics","volume":"51","author":"Madersbacher","year":"2013","journal-title":"Spinal Cord"},{"key":"10.1016\/j.juro.2016.04.046_bib14","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.5489\/cuaj.11187","article-title":"Systematic review of therapy for neurogenic detrusor overactivity","volume":"5","author":"Fowler","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.juro.2016.04.046_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.046_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/11597970-000000000-00000","article-title":"Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies","volume":"29","author":"Sand","year":"2012","journal-title":"Drugs Aging"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716301860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716301860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.04.046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:44:08Z","timestamp":1651207448000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.04.046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1016\/j.juro.2016.04.046"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.04.046","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}